SARS-CoV-2 T-cell response in COVID-19 convalescent patients with and without lung sequelae
A specific T-cell response persists in the majority of COVID-19 patients 6 months after hospital discharge. This response is more prominent in those who required critical care during the acute COVID-19 episode but is reduced in patients with lung sequelae.
| Authors: | , , , , , , , , , , |
|---|---|
| Format: | article |
| Status: | Published version |
| Publication Date: | 2022 |
| Country: | España |
| Institution: | Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| Repository: | Recercat. Dipósit de la Recerca de Catalunya |
| OAI Identifier: | oai:recercat.cat:2445/198563 |
| Online Access: | https://hdl.handle.net/2445/198563 |
| Access Level: | Open access |
| Keyword: | SARS-CoV-2 Pneumònia Pulmó Cèl·lules T Pneumonia Lung T cells |
| Summary: | A specific T-cell response persists in the majority of COVID-19 patients 6 months after hospital discharge. This response is more prominent in those who required critical care during the acute COVID-19 episode but is reduced in patients with lung sequelae. |
|---|